ATE271381T1 - Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler - Google Patents

Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler

Info

Publication number
ATE271381T1
ATE271381T1 AT98908760T AT98908760T ATE271381T1 AT E271381 T1 ATE271381 T1 AT E271381T1 AT 98908760 T AT98908760 T AT 98908760T AT 98908760 T AT98908760 T AT 98908760T AT E271381 T1 ATE271381 T1 AT E271381T1
Authority
AT
Austria
Prior art keywords
providers
transdermal administration
active ingredients
basic active
adhesion systems
Prior art date
Application number
AT98908760T
Other languages
English (en)
Inventor
Jay Audett
Susan E Bailey
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE271381T1 publication Critical patent/ATE271381T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98908760T 1997-02-28 1998-02-27 Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler ATE271381T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/808,211 US5879701A (en) 1997-02-28 1997-02-28 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
PCT/US1998/003832 WO1998037870A1 (en) 1997-02-28 1998-02-27 Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents

Publications (1)

Publication Number Publication Date
ATE271381T1 true ATE271381T1 (de) 2004-08-15

Family

ID=25198190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98908760T ATE271381T1 (de) 1997-02-28 1998-02-27 Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler

Country Status (11)

Country Link
US (1) US5879701A (de)
EP (1) EP0910353B1 (de)
JP (1) JP2000509734A (de)
AT (1) ATE271381T1 (de)
AU (1) AU6670998A (de)
CA (1) CA2252772C (de)
DE (1) DE69825116T2 (de)
DK (1) DK0910353T3 (de)
ES (1) ES2226102T3 (de)
PT (1) PT910353E (de)
WO (1) WO1998037870A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
US6294188B1 (en) 1998-07-09 2001-09-25 Aviana Biopharm Inc. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
FR2814368B1 (fr) * 2000-09-26 2004-05-07 Pf Medicament Preparation pharmaceutique a base d'oxans
DK1335689T3 (da) 2000-10-23 2010-06-14 Euro Celtique Sa System til transdermal indgivelse af loratadin og anvendelse deraf
US7018649B2 (en) * 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods
WO2002054996A2 (en) * 2000-10-23 2002-07-18 Euro Celtique Sa Terazosin transdermal device and methods
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US8840918B2 (en) * 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2445086C (en) * 2001-05-01 2008-04-08 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US20050113510A1 (en) * 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
EP1390084B1 (de) * 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US8496960B2 (en) * 2001-10-23 2013-07-30 Purdue Pharma L.P. Terazosin transdermal device and methods
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
NZ537991A (en) * 2002-08-30 2007-08-31 Alza Corp Embossable and writable multilaminate backing construction
EP1426049B1 (de) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20050096311A1 (en) * 2003-10-30 2005-05-05 Cns Response Compositions and methods for treatment of nervous system disorders
KR20070007299A (ko) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
AU2005271259B2 (en) 2004-08-05 2012-01-19 A.V. Topchiev Institute Of Petrochemical Synthesis Adhesive composition
EP1814531B1 (de) 2004-10-21 2010-06-16 Durect Corporation Transdermale verabreichungssysteme
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
EP1938808B1 (de) * 2005-08-22 2011-01-12 Hisamitsu Pharmaceutical Co., Inc. Zubereitung zur topischen anwendung enthaltend tamsulosin
DE102006026060B4 (de) * 2006-01-12 2013-01-31 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
WO2007117581A2 (en) * 2006-04-06 2007-10-18 Collegium Pharmaceutical, Inc. Stabilized transdermal bupropion preparations
RU2008144405A (ru) * 2006-04-11 2010-05-20 Нитибан Ко, Лтд (Jp) Содержащий тамсулозин трансдермальный пластырь
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
US20100210932A1 (en) * 2007-03-20 2010-08-19 Bayer Healthcare Llc Method of analyzing an analyte
EP1987815A1 (de) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Im Mund-Nasen-Rachenraum verabreichbare pharmazeutische Zusammensetzungen enthaltend Dopaminagonisten zur Vorbeugung und/oder Behandlung von unruhigen Gliedmassen
EP2201941A1 (de) * 2008-12-29 2010-06-30 UCB Pharma GmbH Pflaster-Herstellungstechnologie
CA2751884C (en) * 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
US9072682B2 (en) 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61178915A (ja) * 1985-02-04 1986-08-11 Kotobuki Seiyaku Kk 血圧降下用経皮吸収剤
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
GB9016056D0 (en) * 1990-07-21 1990-09-05 Chatfield Pharmaceuticals Limi Transdermal medicine delivery devices
US5198223A (en) * 1990-10-29 1993-03-30 Alza Corporation Transdermal formulations, methods and devices
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
JPH06510290A (ja) * 1991-08-27 1994-11-17 シグナス，インコーポレイテッド プラゾシンを投与するための経皮処方物
FR2694495B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Préparation pharmaceutique transdermique contenant de l'alfuzosine.
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
ES2172584T3 (es) * 1994-05-18 2002-10-01 Hisamitsu Pharmaceutical Co Preparacion administrable por via percutanea para tratar trastornos de la miccion.
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine

Also Published As

Publication number Publication date
CA2252772A1 (en) 1998-09-03
JP2000509734A (ja) 2000-08-02
WO1998037870A1 (en) 1998-09-03
US5879701A (en) 1999-03-09
DK0910353T3 (da) 2004-11-22
ES2226102T3 (es) 2005-03-16
EP0910353A1 (de) 1999-04-28
DE69825116D1 (de) 2004-08-26
DE69825116T2 (de) 2005-08-04
CA2252772C (en) 2002-04-23
PT910353E (pt) 2004-11-30
EP0910353B1 (de) 2004-07-21
AU6670998A (en) 1998-09-18

Similar Documents

Publication Publication Date Title
ATE271381T1 (de) Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
DK0693924T3 (da) Fremgangsmåde til (in vivo)-levering af biologiske materialer og sammensætninger, der er egnede dertil
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
TR200001545T2 (tr) Plazma proteini içeren farmasötik bileşimler.
MY116296A (en) Cosmetic compositions with dbs and functionalized silicones
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
ATE224705T1 (de) Zusammensetzungen mit kationischen amphiphilen und colipiden zur intrazellulären verabreichung therapeutischer moleküle
DK0758248T3 (da) Formuleringer til faktor IX
GT199700079A (es) Derivados triciclos sustituidos con fenilamino
ES2183865T3 (es) Preparaciones de doble capa de galactolipido que contienen digalactosildiacilglicerol.
DE69528057D1 (de) Tocopherolzusammensetzungen zur Abgabe von biologisch aktiven Substanzen
FI914391A0 (fi) Sammansaettningar vilka foerstaerker hudens permeabilitet.
DE3783039D1 (de) Membran lipid zusammensetzung und verfahren zur herstellung.
PL338335A1 (en) Pharmaceutic composition in the of self-emulsifiable formulation of lipophilic compounds
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
PT1069886E (pt) Formulacoes topica do tipo oleo-em-agua compreendendo um material galactolipidico como emulsionante com um efeito prolongado de uma substancia activa incorporada
MY101919A (en) Pharmaceutical compositions
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
WO1999006388A3 (en) Pharmaceutical compounds isolated from aristolochia taliscana
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
ES2133918T3 (es) Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen.
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0910353

Country of ref document: EP